| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
645 |
600 |
$662K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,798 |
3,355 |
$593K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
879 |
842 |
$360K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,538 |
4,032 |
$347K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
869 |
839 |
$100K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
194 |
189 |
$93K |
| 71046 |
Radiologic examination, chest; 2 views |
319 |
303 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,341 |
4,429 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
920 |
874 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
209 |
203 |
$31K |
| 71045 |
Radiologic examination, chest; single view |
274 |
266 |
$28K |
| 36415 |
Collection of venous blood by venipuncture |
3,420 |
2,786 |
$28K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
181 |
181 |
$26K |
| 76830 |
Ultrasound, transvaginal |
132 |
131 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,357 |
1,258 |
$21K |
| 80051 |
|
3,364 |
2,976 |
$18K |
| 82565 |
|
4,422 |
3,748 |
$17K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
85 |
85 |
$13K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
475 |
454 |
$10K |
| 82947 |
|
3,485 |
3,034 |
$10K |
| 84460 |
|
2,734 |
2,303 |
$10K |
| 82247 |
|
2,459 |
2,005 |
$9K |
| 84520 |
|
3,373 |
2,981 |
$9K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
54 |
54 |
$7K |
| 83880 |
|
279 |
259 |
$7K |
| J3490 |
Unclassified drugs |
1,051 |
580 |
$7K |
| 84450 |
|
2,172 |
1,886 |
$7K |
| 83690 |
|
1,448 |
1,356 |
$6K |
| 81001 |
|
2,060 |
1,895 |
$6K |
| 84075 |
|
1,845 |
1,669 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
281 |
278 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
24 |
24 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
980 |
875 |
$5K |
| 84702 |
|
255 |
176 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
152 |
143 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
85 |
85 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
348 |
346 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
14 |
14 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
31 |
30 |
$3K |
| 83735 |
|
652 |
537 |
$3K |
| 80061 |
Lipid panel |
192 |
191 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
80 |
71 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
80 |
71 |
$3K |
| 85652 |
|
689 |
670 |
$2K |
| 81003 |
|
1,241 |
1,193 |
$2K |
| 0450 |
Emergency room services |
33 |
30 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
269 |
257 |
$2K |
| 76770 |
|
13 |
13 |
$2K |
| 73110 |
|
13 |
12 |
$2K |
| 84132 |
|
327 |
277 |
$2K |
| 85027 |
|
247 |
239 |
$1K |
| 87088 |
|
287 |
274 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
398 |
380 |
$1K |
| 82728 |
|
89 |
89 |
$1K |
| 85610 |
|
415 |
333 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
242 |
238 |
$1K |
| 0637 |
|
1,964 |
797 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
353 |
341 |
$1K |
| 84484 |
|
359 |
332 |
$1K |
| 84100 |
|
384 |
330 |
$1K |
| 84295 |
|
206 |
127 |
$1K |
| 82310 |
|
187 |
159 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27 |
27 |
$910.49 |
| 85379 |
|
128 |
126 |
$666.42 |
| 83605 |
|
234 |
221 |
$644.42 |
| 82077 |
|
183 |
161 |
$639.90 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
303 |
285 |
$637.79 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
66 |
66 |
$637.31 |
| 87040 |
|
167 |
161 |
$605.24 |
| 86140 |
|
121 |
121 |
$593.98 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
32 |
32 |
$559.21 |
| 84703 |
|
265 |
250 |
$557.37 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
344 |
314 |
$479.28 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
17 |
16 |
$463.00 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
171 |
167 |
$388.16 |
| 82607 |
|
26 |
26 |
$383.33 |
| 82040 |
|
71 |
64 |
$339.80 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
252 |
234 |
$334.10 |
| 80306 |
|
25 |
24 |
$242.64 |
| 82248 |
|
76 |
72 |
$233.94 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
107 |
105 |
$191.59 |
| 80178 |
|
28 |
24 |
$150.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
111 |
106 |
$125.20 |
| 85730 |
|
12 |
12 |
$85.34 |
| 0250 |
|
169 |
129 |
$9.49 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
12 |
$9.13 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
24 |
24 |
$0.00 |